Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML
Author:
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Link
http://www.nature.com/articles/1705240.pdf
Reference26 articles.
1. Walters MC, Patience M, Leisenring W, Eckman JR, Scott JJ, Mentzer WC et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996; 335: 369–376.
2. Lucarelli G, Clift RA, Galimberti M, Angelucci E, Giardini C, Baronciani D et al. Bone marrow transplantation in adult thalassemic patients. Blood 1999; 93: 1164–1167.
3. Peters C, Steward CG, on behalf of the NMDP, IBMTR and the Working Party on Inborn Errors of the EBMT. Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines. Bone Marrow Transplant 2003; 31: 229–239.
4. Antoine C, Muller S, Cant A, Cavazzana-Calvo M, Veyes P, Vossen J et al. Long-term survival and transplantation of hematopoietic stem cells for immunodeficiencies: report of the European experience 1968–1999. Lancet 2003; 361: 553–560.
5. Clift RA, Buckner CD, Thomas ED, Bensinger WI, Bowden R, Brayant E et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood 1994; 84: 2036–2043.
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unrelated umbilical cord blood transplantation using a noval conditioning regimen for small month-old infants with rare non-malignant disorders;2024-08-26
2. Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study;Journal of Allergy and Clinical Immunology;2024-01
3. Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab;Pediatric Hematology and Oncology;2023-12-22
4. Feasibility study of busulfan, fludarabine, and thiotepa conditioning regimen for allogeneic hematopoietic stemcell transplantationfor children and young adults with nonmalignant disorders;Pediatric Blood & Cancer;2023-04-12
5. Two‐point blood sampling is sufficient and necessary to estimate the area under the concentration‐time curve for intravenous busulfan in infants and young children;Pediatric Blood & Cancer;2021-04-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3